By Dave Sebastian

Eli Lilly & Co. and Amgen Inc. said they are collaborating on making Lilly's potential Covid-19 antibody therapies, in an effort to boost supply if the treatment is approved.

The two companies expect to produce millions of doses next year, said Daniel Skovronsky, Lilly's chief scientific officer and president of Lilly Research Laboratories.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

September 17, 2020 06:55 ET (10:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Amgen Charts.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Amgen Charts.